Basic Neurosciences · Paper A
Receptor target of zopiclone
The reason this pairing of zopiclone with the benzodiazepine binding site keeps coming up is that the exam wants you to see the underlying logic: drugs from completely different chemical families can converge on the exact same receptor site and produce a similar clinical effect. In practice, this means a stem describing a "non-benzodiazepine hypnotic" or a "Z-drug" is testing whether the reader can identify that it still acts through the benzodiazepine site on GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more →-A, not a different mechanism entirely. This connects directly to why zopiclone shares benzodiazepines' main risks — toleranceNeeding a larger dose of a drug over time to get the same effect.Read more →, dependence, and additive sedation with alcohol or opioids — despite being chemically unrelated to them. Clinically, this matters because it explains why flumazenil, the benzodiazepine antagonistA drug that blocks a receptor, stopping it from being activated.Read more → used in overdose, also reverses zopiclone toxicity by displacing it from the same binding site.
Zopiclone works by binding the benzodiazepine binding site on the GABA-A receptorA receptor for the calming brain chemical GABA, and the site where benzodiazepines and alcohol produce their sedating effect.Read more → complex, the same site that classical benzodiazepines such as diazepam use. GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more → (gamma-aminobutyric acid) is the brain's main inhibitory neurotransmitterA chemical messenger that nerve cells release to signal to the next cell.Read more →, and the GABA-A receptor is a chloride channel that opens when GABA binds, letting chloride ions flow into the neuron and making it less likely to fire. When zopiclone occupies the benzodiazepine binding site, it does not open the channel on its own; instead it makes the receptor more sensitive to GABA, so the channel opens more often and produces sedation, muscle relaxation and anti-anxiety effects. Zopiclone belongs to the cyclopyrrolone chemical class, structurally distinct from the benzodiazepines, which is why it is often called a "Z-drug" alongside zolpidem and zaleplon.
A stem describing a "non-benzodiazepine hypnotic" or "Z-drug" prescribed for insomnia. A question asking which receptor a Z-drug shares with benzodiazepines. A question about flumazenil reversing sedation from a hypnotic that is not itself a benzodiazepine. A question contrasting zopiclone's chemical class (cyclopyrrolone) against diazepam's (benzodiazepine). A comparison of zopiclone against melatonin or orexin-receptor hypnotics, which act through unrelated mechanisms.
Zopiclone (cyclopyrrolone "Z-drug")acts at the benzodiazepine binding site on GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more →-A, relatively short half-lifeThe time it takes for the amount of a drug in the body to fall by half.Read more →, marketed mainly for insomnia rather than anxiety. Diazepam (benzodiazepine): also acts at the benzodiazepine binding site on GABA-A, but longer half-life and broader anxiolyticA drug that reduces anxiety.Read more →/anticonvulsant use. Melatonin/ramelteon: act at melatonin MT1/MT2 receptors, an entirely separate circadian mechanism, not GABA-A. Suvorexant: an orexin receptor antagonistA drug that blocks a receptor, stopping it from being activated.Read more →, another separate mechanism unrelated to GABA-A.
Assuming because zopiclone is "non-benzodiazepine" it must act on a different receptor — it shares the exact same benzodiazepine binding site on GABAThe brain's main calming (inhibitory) chemical messenger, boosted by benzodiazepines and alcohol.Read more →-A, it is just chemically a different molecule. Assuming zopiclone is free of dependence risk because it is not chemically a benzodiazepine — toleranceNeeding a larger dose of a drug over time to get the same effect.Read more → and dependence can still occur with prolonged use. Confusing zopiclone's cyclopyrrolone class with the benzodiazepine class itself when a question asks for the specific chemical class.
When a stem names a drug as "non-X" but clinically behaves like X, check whether it shares X's receptor site through a different chemical scaffold rather than assuming an unrelated mechanism — this pattern repeats across pharmacology (Z-drugs and benzodiazepines being the classic example).